JPMorgan Chase & Co’s Cadrenal Therapeutics CVKD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-100
Closed -$1.76K 6250
2025
Q1
$1.76K Buy
+100
New +$1.76K ﹤0.01% 5687